Artemis Hospitals
| India | Turkey | Austria | |
| Plasmapheresis | from $4,200 | from $1,200 | from $2,000 |
| Ocrevus (ocrelizumab) | from $18,200 | from $10,000 | from $35,000 |
| Multiple sclerosis rehabilitation | from $3,200 | from $3,000 | from $10,000 |
| Medication treatment for multiple sclerosis | from $3,200 | from $2,500 | from $2,000 |
| Therapeutic Apheresis | from $850 | from $1,350 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Multiple sclerosis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Multiple sclerosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Multiple sclerosis treatment journey.
Dr. Sridhar Krishnamurthy is the Director of the Institute of Neurosciences and Spinal Disorders in Chennai. He is an inventor of specialized surgical tools like the Sridhar Spinal Retractor System. Dr. Krishnamurthy trained at top institutions in Germany and Switzerland. He currently treats complex cases at Global Hospital Chennai.
Dr. Ravi Mohanka has performed over 1,300 transplants with an 88% patient survival rate. He is the Head of Liver Transplant and Hepato-Biliary Surgery at Global Hospital Mumbai. Dr. Mohanka specializes in liver, pancreas, and intestinal transplants for adults and children. He fits complex cases using laparoscopic and robotic surgical techniques.
Multiple Sclerosis is treatable in India through advanced disease-modifying therapies and specialized neuro-rehabilitation. Leading JCI-accredited centers in Delhi, Mumbai, and Bengaluru offer modern infusions like Ocrelizumab. Treatment focus remains on managing relapses and slowing progression using international medical protocols and diagnostic imaging.
Bookimed Expert Insight: While many believe specialized care is limited to the capital, Manipal Hospitals in Bengaluru serves 2 million patients annually across a massive 15-hospital network. This scale allows them to maintain consistent stocks of newer disease-modifying therapies that are often unavailable in smaller regional centers.
Patient Consensus: Patients emphasize that getting diagnosed in major metropolitan hospitals is faster than in government facilities. Many note the importance of joining support groups to find affordable generic medication suppliers and active clinical trials.
Advanced Multiple Sclerosis treatments like Hematopoietic Stem Cell Transplantation (HSCT) in India show success rates between 80% and 90% for halting disease progression. Outcomes are highest for Relapsing-Remitting Multiple Sclerosis (RRMS) patients. Indian centers utilize global auto-SCT protocols within Joint Commission International (JCI) accredited facilities.
Bookimed Expert Insight: While many focus on Delhi or Mumbai, Apollo Hospital Indraprastha in Delhi stands out as the largest transplantation center outside the USA. This high volume is a critical quality signal. Data shows centers performing more transplants typically manage post-chemotherapy recovery more effectively, which is vital for MS patients whose primary risk is infection during the 3-month recovery window.
Patient Consensus: Patients note that while the procedure is life-changing, intense chemotherapy side effects require strict isolation. Many emphasize tracking baseline MRI data carefully to measure long-term success accurately.
India offers advanced Multiple Sclerosis treatment at JCI-accredited facilities in Delhi, Mumbai, and Gurgaon. Leading centers like Artemis Hospitals and Apollo Hospital Indraprastha provide specialized neuroimaging, plasma exchange, and monoclonal antibody therapies. These hospitals integrate neurology with multidisciplinary rehabilitation for comprehensive patient care.
Bookimed Expert Insight: Patient volume data highlights a significant gap in service speed between private and public sectors. While AIIMS Delhi is a premier research center, private networks like Manipal Hospitals serve over 2,000,000 patients annually with significantly shorter wait times. Choosing a facility in the Manipal or Apollo network often ensures quicker access to critical infusions like Ocrevus compared to the typical 6-month wait in public institutions.
Patient Consensus: Patients note that private clinics in Mumbai and Bangalore offer faster access to diagnostic tests like evoked potentials. Many emphasize joining local support groups to find the most affordable pricing for high-quality generic medications.
India provides a diverse range of recognized complementary treatments through the Ministry of AYUSH. These therapies include Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy. While not curative for multiple sclerosis, they serve as adjunctive care to manage symptoms alongside conventional neurological treatments.
Bookimed Expert Insight: Patients often overlook that India's largest medical networks, such as Manipal or Apollo, provide access to 1,900+ doctors. This scale allows patients to combine advanced neurology with recognized alternative medicine in one city. Choosing a facility with both JCI and NABH accreditations ensures that complementary therapies meet international safety standards.
Patient Consensus: Patients emphasize that while Ayurveda and Yoga help significantly with mental health and mobility, they must never replace disease-modifying therapies. Many note that Vitamin D and B12 supplementation is essential in India due to high local deficiency rates.
The Indian government supports MS patients through the Rights of Persons with Disabilities Act 2016. This provides legal recognition and workplace protection. Patients can access subsidized care at AIIMS and through the Central Government Health Scheme. Financial aid primarily comes from state-specific welfare programs and NGOs.
Bookimed Expert Insight: While national drug subsidies are limited, top private centers like Manipal Hospitals and Apollo Indraprastha offer advanced diagnostics like MRI and CT. Private facilities often provide faster access to specialized neurologists like Dr. Hitesh Kumar. Patients at these JCI-accredited hubs can access multidisciplinary care that smaller government centers may lack.
Patient Consensus: Patients note that government aid is often patchy and mostly covers basic mobility aids. Many suggest applying for state disability certificates immediately to secure monthly pensions and potential medication discounts.
India offers comprehensive Multiple Sclerosis (MS) care. This includes disease-modifying therapies, plasma exchange, and ocrelizumab infusions. JCI-accredited centres like Apollo Hospital Indraprastha and Artemis Hospitals provide integrated neurology services. Treatments range from acute relapse management with corticosteroids to neuro-rehabilitation and neuro-regenerative approaches.
Bookimed Expert Insight: While many centres offer standard care, choosing a facility in a major metro ensures better access. Cities like Delhi or Mumbai offer the Full Time Specialist System. Clinics like Kokilaben Dhirubhai Ambani Hospital use this model to guarantee neurologist availability for urgent relapse management.
Patient Consensus: Patients note that drug availability varies by city. They advise confirming specific brand registrations before travel. Those visiting India emphasise coordinating a long-term plan for continuing infusions after returning to Australia.
Autologous Haematopoietic Stem Cell Transplantation (HSCT) for Multiple Sclerosis is available in India at several JCI-accredited facilities. Specialist teams at centres like BLK Super Speciality Hospital and Apollo Hospital Indraprastha perform this procedure. It is most effective for aggressive relapsing-remitting cases with active inflammation.
Bookimed Expert Insight: India's largest medical networks provide a significant institutional advantage for complex transplants. For example, Manipal Hospitals operates 15 sites and serves 2,000,000 patients annually. This massive volume helps Indian haematologists maintain high proficiency in isolation protocols and neutropenic care. Patients should prioritse these high-volume networks which hold quality markers like NABH and ISO certification.
Patient Consensus: Patients emphasise the need to confirm that the facility offers autologous HSCT specifically. This is different from general stem cell therapy. They note it is vital to verify the haematology team’s experience with Multiple Sclerosis cases in India.
Multiple sclerosis treatment in India is best sought at JCI-accredited facilities like Artemis Hospitals and Apollo Hospital Indraprastha. These centres provide disease-modifying therapies and plasmapheresis. Dedicated departments offer specialised neuro-rehabilitation and neuro-immunology clinics for comprehensive care.
Bookimed Expert Insight: Indian medical networks such as Manipal and Apollo serve over 1,000,000 patients annually. This massive scale allows doctors like Dr Hitesh Kumar to manage rare neuro-immunological variations regularly. Patients should choose Gurgaon or Delhi hubs where these large neurological departments are concentrated.
Neuro-rehabilitation in India provides integrated support for multiple sclerosis through specialised hospital networks and dedicated clinics. Patients access physical, occupational, and speech therapies alongside treatments like plasmapheresis. JCI-accredited facilities in Delhi, Mumbai, and Bengaluru offer structured inpatient and outpatient programmes focused on functional recovery.
Bookimed Expert Insight: Patients seeking intensive recovery should target JCI-accredited networks like Apollo or Manipal Hospitals. These major groups serve over 1,000,000 patients annually. Internal data shows they offer more comprehensive physical therapy equipment than smaller private centres. Their NABL-accredited labs are vital for Australians requiring internationally recognised monitoring of Ocrevus.
Patient Consensus: Patients note it is important to look for Indian city subreddits. These often mention local gait training and neurologic clinics. Many find that multi-specialty physiotherapy centres provide a more personalised atmosphere for long-term maintenance.
Health insurance for multiple sclerosis treatment in India is restrictive and often excludes outpatient care. Policies usually involve lump-sum critical illness payouts or hospitalisation indemnity. Patients must serve a 2 to 4 year waiting period for pre-existing conditions. Standard plans rarely cover ongoing oral medications.
Bookimed Expert Insight: JCI-accredited hubs like Apollo Hospital Indraprastha and Manipal Hospitals handle large international volumes. Apollo alone serves 1,000,000 patients annually. While insurance is complex, generic biosimilars in India significantly reduce the financial burden. This helps those paying without full coverage.
Patient Consensus: Patients in India suggest getting insurer pre-approval in writing. They also recommend verifying if the hospital offers direct billing. Many facilities require upfront payment with reimbursement occurring after returning home.